Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Valerie Morisset Insider Profile
4 Followers
Valerie Morisset, EVP, R&D AND CSO at Climb Bio, holds 31.32K shares in Climb Bio (Ticker: CLYM). Most recently, Valerie Morisset Sold $129,206 shares of Climb Bio on Jul 23, 2024 for an estimated value of 988.50K.
Profitable Transactions
7 out of 7 Profitable Transactions
Average Return
+72.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Valerie Morisset's holdings
Insider Roles
EVP, R&D AND CSO
Roles that Valerie Morisset holds in companies
Most Profitable Insider Trade
The most profitable trade made by Valerie Morisset
Valerie Morisset's Trading History
List of latest transactions for each holding click on a transaction to see Valerie Morisset's performance on stock
You May Also Like
Valerie Morisset insider profile FAQ
What is the percentage of profitable transactions made by Valerie Morisset?
The percentage of profitable transactions made by Valerie Morisset is 100%.
What is the average return per transaction made by Valerie Morisset?
The average return per transaction made by Valerie Morisset is 72.70%.
What stocks does Valerie Morisset hold?
Valerie Morisset holds: CLYM stocks.
What was Valerie Morisset’s latest transaction?
Valerie Morisset latest transaction was an Informative Sell of $988.50K.
What was Valerie Morisset's most profitable transaction?
Valerie Morisset’s most profitable transaction was an Informative Sell of CLYM stock on July 23, 2024. The return on the trade was 78.10%.
What is Valerie Morisset's role in Climb Bio?
Valerie Morisset's role in Climb Bio is EVP, R&D AND CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.